The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies
Abstract
Diabetes mellitus is a heterogeneous chronic metabolic disorder characterized by the presence of hyperglycemia, commonly preceded by a prediabetic state. The excess of blood glucose can damage multiple organs, including the brain. In fact, cognitive decline and dementia are increasingly being recognized as important comorbidities of diabetes. Despite the largely consistent link between diabetes and dementia, the underlying causes of neurodegeneration in diabetic patients remain to be elucidated. A common factor for almost all neurological disorders is neuroinflammation, a complex inflammatory process in the central nervous system for the most part orchestrated by microglial cells, the main representatives of the immune system in the brain. In this context, our research question aimed to understand how diabetes affects brain and/or retinal microglia physiology. We conducted a systematic search in PubMed and Web of Science to identify research items addressing the effects of diabetes on microglial phenotypic modulation, including critical neuroinflammatory mediators and their pathways. The literature search yielded 1327 records, including 18 patents. Based on the title and abstracts, 830 papers were screened from which 250 primary research papers met the eligibility criteria (original research articles with patients or with a strict diabetes model without comorbidities, that included direct data about microglia in the brain or retina), and 17 additional research papers were included through forward and backward citations, resulting in a total of 267 primary research articles included in the scoping systematic review. We reviewed all primary publications investigating the effects of diabetes and/or its main pathophysiological traits on microglia, including in vitro studies, preclinical models of diabetes and clinical studies on diabetic patients. Although a strict classification of microglia remains elusive given their capacity to adapt to the environment and their morphological, ultrastructural and molecular dynamism, diabetes modulates microglial phenotypic states, triggering specific responses that include upregulation of activity markers (such as Iba1, CD11b, CD68, MHC-II and F4/80), morphological shift to amoeboid shape, secretion of a wide variety of cytokines and chemokines, metabolic reprogramming and generalized increase of oxidative stress. Pathways commonly activated by diabetes-related conditions include NF-κB, NLRP3 inflammasome, fractalkine/CX3CR1, MAPKs, AGEs/RAGE and Akt/mTOR. Altogether, the detailed portrait of complex interactions between diabetes and microglia physiology presented here can be regarded as an important starting point for future research focused on the microglia–metabolism interface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, HFD resulted in increased CD68 staining as a proxy of phagocytic activity[73,75,85].”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [73]
In the citing paper
“Furthermore, CD68 staining, a proxy of phagocytic activity[73,75,77], further confirm that hypothalamic microglia exist in an activated state in response to HFD, which is reversed upon C3aR deletion (Fig.4D–E).”
From Complement 3a Receptor mediates high fat diet induced hypothalamic accumulation of lipid associated microglia to regulate neuroinflammation and obesity (2026) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Microglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999
Milanski, M., Degasperi, G., Coope, A., Morari, J., Denis, R., Cintra, D. E., Tsukumo, D. M. L., Anhe, G., Amaral, M. E., Takahashi, H. K., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2760-08.2009 · Cited by 1,125
Valdearcos, M., Robblee, M. M., Benjamin, D. I., Nomura, D. K., Xu, A. W., & Koliwad, S. K. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.018 · Cited by 629
Valdearcos, M., Douglass, J. D., Robblee, M. M., Dorfman, M. D., Stifler, D. R., Bennett, M. L., Gerritse, I., Fasnacht, R., Barres, B. A., Thaler, J. P., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.015 · Cited by 477
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function
Bocarsly, M. E., Fasolino, M., Kane, G. A., LaMarca, E. A., Kirschen, G. W., Karatsoreos, I. N., McEwen, B. S., & Gould, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511593112 · Cited by 250
White, C. L., Pistell, P. J., Purpera, M. N., Gupta, S., Fernandez-Kim, S.-O., Hise, T. L., Keller, J. N., Ingram, D. K., Morrison, C. D., & Bruce-Keller, A. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.002 · Cited by 245
Microglial UCP2 mediates inflammation and obesity induced by high-fat feeding
Kim, J. D., Yoon, N. A., Jin, S., & Diano, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.010 · Cited by 240
Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling
Wang, Z., Liu, D., Wang, F., Liu, S., Zhao, S., Ling, E.-A., & Hao, A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511002868 · Cited by 239
Inhibiting microglia expansion prevents diet-induced hypothalamic and peripheral inflammation
André, C., Guzman-Quevedo, O., Rey, C., Rémus-Borel, J., Clark, S., Castellanos-Jankiewicz, A., Ladeveze, E., Leste-Lasserre, T., Nadjar, A., Abrous, D. N., et al. (2017) · Diabetes · doi:10.2337/db16-0586 · Cited by 182 · cited 3×
“Other evidence supporting diet-induced activation of the NF-κB pathway in the hippocampus comes from the decreased expression of IκBα, a negative regulator of NF-κB, in HFD-fed mice [150].”
Background
Research works printed but not linked: 257
- Prinz M, Masuda T, Wheeler MA, Quintana FJ. Microglia and central nervous system-associated macrophages—from origin to disease modulation. Annu Rev Immunol. 2021;39:251–77. · DOI · Paper page
- Paolicelli RC, Sierra A, Stevens B, Tremblay M-E, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458–83. · DOI · Paper page
- World Health Organization. Classification of diabetes mellitus. Geneva: World Health Organization; 2019.
- Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertension. 2011;13:244–51. · DOI · Paper page
- Song J, Lee JE. ASK1 modulates the expression of microRNA Let7A in microglia under high glucose in vitro condition. Front Cell Neurosci. 2015;9. · DOI
- Liu H, Bian W, Yang D, Yang M, Luo H. Inhibiting the Piezo1 channel protects microglia from acute hyperglycaemia damage through the JNK1 and mTOR signalling pathways. Life Sci. 2021;264: 118667. · DOI
- Wang JY, Yang JM, Wang JY, Tao PL, Yang SN. Synergistic apoptosis induced by bacterial endotoxin lipopolysaccharide and high glucose in rat microglia. Neurosci Lett. 2001;304:177–80. · DOI
- Wang L-Q, Zhou H-J. LncRNA MALAT1 promotes high glucose-induced inflammatory response of microglial cells via provoking MyD88/IRAK1/TRAF6 signaling. Sci Rep. 2018;8:8346. · DOI
- Huang L, You J, Yao Y, Xie M. High glucose induces pyroptosis of retinal microglia through NLPR3 inflammasome signaling. Arq Bras Oftalmol Brazil. 2021;84:67–73.
- Baptista FI, Aveleira CA, Castilho AF, Ambrosio AF. Elevated glucose and interleukin-1 beta differentially affect retinal microglial cell proliferation. Mediators Inflamm. 2017;2017:4316316. · DOI
- Quan Y, Du J, Wang X. High glucose stimulates GRO secretion from rat microglia via ROS, PKC, and NF-kappa B pathways. J Neurosci Res. 2007;85:3150–9. · DOI
- Guang-chan J, Meng-ren Z, Chao J, Ping-ping Z, Yu-qin L, Bei G. Effect of Chinese herbal compound Naofucong on the inflammatory process induced by high glucose in BV-2 cells. Chin J Integr Med. 2016;22:832–9. · DOI
- Shi Y, Guo X, Zhang J, Zhou H, Sun B, Feng J. DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA. Brain Behav Immun. 2018;73:482–92. · DOI
- Yang L, Tong Y, Chen P-F, Miao S, Zhou R. Neuroprotection of dihydrotestosterone via suppression of the toll-like receptor 4/nuclear factor-kappa B signaling pathway in high glucose-induced BV-2 microglia inflammatory responses. NeuroReport. 2020;31:139–47. · DOI
- Liu X, Xu B, Gao S. Spleen tyrosine kinase mediates microglial activation in mice with diabetic retinopathy. Transl Vis Sci Technol. 2021;10:20. · DOI
- Mei X, Zhou L, Zhang T, Lu B, Sheng Y, Ji L. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Vascul Pharmacol. 2018;101:29–37. · DOI
- Mei X, Zhang T, Ouyang H, Lu B, Wang Z, Ji L. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Biochem Pharmacol. 2019;159:82–95. · DOI
- Li H, Mei X-Y, Wang M-N, Zhang T-Y, Zhang Y, Lu B, et al. Scutellarein alleviates the dysfunction of inner blood-retinal-barrier initiated by hyperglycemia-stimulated microglia cells. Int J Ophthalmol. 2020;13:1538–45. · DOI
- Zhang T, Mei X, Ouyang H, Lu B, Yu Z, Wang Z, et al. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy. J Nutr Biochem. 2019;65:1–14. · DOI
- Zhang T, Ouyang H, Mei X, Lu B, Yu Z, Chen K, et al. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-kappa B signaling pathway. FASEB J. 2019;33:11776–90. · DOI
- Zhu S-H, Liu B-Q, Hao M-J, Fan Y-X, Qian C, Teng P, et al. Paeoniflorin suppressed high glucose-induced retinal microglia MMP-9 expression and inflammatory response via inhibition of TLR4/NF-κB pathway through upregulation of SOCS3 in diabetic retinopathy. Inflammation. 2017;40:1475–86. · DOI
- Huang Y, Liao Z, Lin X, Wu X, Chen X, Bai X, et al. Overexpression of miR-146a might regulate polarization transitions of BV-2 cells induced by high glucose and glucose fluctuations. Front Endocrinol. 2019;10:719. · DOI
- Quan Y, Jiang C, Xue B, Zhu S, Wang X. High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways. Acta Pharmacol Sin. 2011;32:188–93. · DOI
- Zhang X, Dong H, Zhang S, Lu S, Sun J, Qian Y. Enhancement of LPS-induced microglial inflammation response via TLR4 under high glucose conditions. Cell Physiol Biochem. 2015;35:1571–81. · DOI · Paper page
- Yun J-H, Park SW, Kim K-J, Bae J-S, Lee EH, Paek SH, et al. Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: implications for diabetic retinopathy. J Cell Physiol United States. 2017;232:1123–34. · DOI
- Yun J-H, Lee D-H, Jeong H-S, Kim HS, Ye S-K, Cho C-H. STAT3 activation in microglia exacerbates hippocampal neuronal apoptosis in diabetic brains. J Cell Physiol. 2021;236:7058–70. · DOI
- Yun J-H. Interleukin-1β induces pericyte apoptosis via the NF-κB pathway in diabetic retinopathy. Biochem Biophys Res Commun United States. 2021;546:46–53. · DOI
- Li Y, Long W, Gao M, Jiao F, Chen Z, Liu M, et al. TREM2 regulates high glucose-induced microglial inflammation via the NLRP3 signaling pathway. Brain Sci. 2021;11:896. · DOI
- Chen C, Wu S, Hong Z, Chen X, Shan X, Fischbach S, et al. Chronic hyperglycemia regulates microglia polarization through ERK5. Aging-Us. 2019;11:697–706. · DOI
- Yu Z, Zhang T, Gong C, Sheng Y, Lu B, Zhou L, et al. Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1 alpha-VEGF/VEGFR2 signaling pathway. Sci Rep. 2016;6:34306. · DOI
- de Simoes Pereira TO, Ferreira da Costa GN, Saraban do Santiago AR, Ambrosio AF, Martins dos Santos PF. High glucose enhances intracellular Ca2+ responses triggered by purinergic stimulation in retinal neurons and microglia. Brain Res. 2010;1316:129–38. · DOI
- Hsieh C-F, Liu C-K, Lee C-T, Yu L-E, Wang J-Y. Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep. 2019;9:840. · DOI
- Hininger-Favier I, Thangthaeng N, Bielinski DF, Fisher DR, Poulose SM, Shukitt-Hale B. Blueberries and insulin protect microglial cells against high glucose-induced inflammation and restore GLUT-1. J Berry Res. 2021;11:201–16. · DOI
- Fang M, Wan W, Li Q, Wan W, Long Y, Liu H, et al. Asiatic acid attenuates diabetic retinopathy through TLR4/MyD88/NF-κB p65 mediated modulation of microglia polarization. Life Sci. 2021;277:119567. · DOI
- Bernier L-P, York EM, Kamyabi A, Choi HB, Weilinger NL, MacVicar BA. Microglial metabolic flexibility supports immune surveillance of the brain parenchyma. Nat Commun. 2020;11:1559. · DOI · Paper page
- Shen Y, Kapfhamer D, Minnella AM, Kim J-E, Won SJ, Chen Y, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun. 2017;8:624. · DOI
- Castillo E, Mocanu E, Uruk G, Swanson RA. Glucose availability limits microglial nitric oxide production. J Neurochem. 2021;159:1008–15. · DOI
- Stolzing A, Widmer R, Jung T, Voss P, Grune T. Degradation of glycated bovine serum albumin in microglial cells. Free Radical Biol Med. 2006;40:1017–27. · DOI
- Shen C, Ma Y, Zeng Z, Yin Q, Hong Y, Hou X, et al. RAGE-specific inhibitor FPS-ZM1 attenuates AGEs-induced neuroinflammation and oxidative stress in rat primary microglia. Neurochem Res. 2017;42:2902–11. · DOI
- Sabokdast M, Habibi-Rezaei M, Moosavi-Movahedi AA, Ferdousi M, Azimzadeh-Irani E, Poursasan N. Protection by beta-hydroxybutyric acid against insulin glycation, lipid peroxidation and microglial cell apoptosis. Daru-J Pharmaceut Sci. 2015;23:42. · DOI
- Schmitt A, Bigl K, Meiners I, Schmitt J. Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures. Biochim Biophys Acta (BBA) Mol Cell Res. 2006;1763:927–36. · DOI
- Wang AL, Yu ACH, He QH, Zhu X, Tso MOM. AGEs mediated expression and secretion of TNF alpha in rat retinal microglia. Exp Eye Res England. 2007;84:905–13. · DOI
- Wang L, Chen K, Liu K, Zhou Y, Zhang T, Wang B, et al. DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARγ/NFκB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts. Neurochem Res. 2015;40:713–22. · DOI
- Liu W, Xu GZ, Jiang CH, Tian J. Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro. BMC Cell Biol. 2011;12:5. · DOI
- Udomruk S, Wudtiwai B, Shwe TH, Phitak T, Pothacharoen P, Phimphilai M, et al. Sesamin suppresses advanced glycation end products induced microglial reactivity using BV2 microglial cell line as a model. Brain Res Bull. 2021;172:190–202. · DOI
- Chang K-C, Shieh B, Petrash JM. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem Biol Interact. 2019;302:46–52. · DOI
- Shaikh SB, Uy B, Perera A, Nicholson LFB. AGEs–RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem Int. 2012;60:640–51. · DOI
- Wang AL, Li Z, Yuan M, Yu ACH, Zhu X, Tso MOM. Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products. Int Immunopharmacol Netherlands. 2007;7:1552–8. · DOI
- Dong N, Xu B, Shi H, Lu Y. miR-124 regulates amadori-glycated albumin-induced retinal microglial activation and inflammation by targeting Rac1. Invest Ophthalmol Vis Sci. 2016;57:2522–32. · DOI
- Wong A, Dukic-Stefanovic S, Gasic-Milenkovic J, Schinzel R, Wiesinger H, Riederer P, et al. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia: inhibition of NO synthase induction by antioxidants. Eur J Neurosci. 2001;14:1961–7. · DOI
- Dong N, Li X, Xiao L, Yu W, Wang B, Chu L. Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro. Invest Ophthalmol Vis Sci. 2012;53:7567–75. · DOI
- Dong N, Chang L, Wang B, Chu L. Retinal neuronal MCP-1 induced by AGEs stimulates TNF-α expression in rat microglia via p38, ERK, and NF-κB pathways. Mol Vis. 2014;20:616–28.
- Dong N, Xu B, Shi H. Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism. Inflamm Res. 2018;67:913–25. · DOI
- Hidalgo-Lanussa O, Avila-Rodriguez M, Baez-Jurado E, Zamudio J, Echeverria V, Miguel Garcia-Segura L, et al. Tibolone reduces oxidative damage and inflammation in microglia stimulated with palmitic acid through mechanisms involving estrogen receptor beta. Mol Neurobiol. 2018;55:5462–77. · DOI
- Oh S, Son M, Choi J, Choi CH, Park KY, Son KH, et al. Phlorotannins from ecklonia cava attenuates palmitate-induced endoplasmic reticulum stress and leptin resistance in hypothalamic neurons. Mar Drugs. 2019;17:570. · DOI
- Cui Y, Yang M, Wang Y, Ren J, Lin P, Cui C, et al. Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway. FASEB J. 2021;35: e21485. · DOI
- Morris G, Puri BK, Maes M, Olive L, Berk M, Carvalho AF. The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109858. · DOI
- Chen H, Souayah N. Immunoglobulins reduced oxidative stress in human microglial cells induced by high dose of acetoacetate. Brain Res Netherlands. 2020;1748: 147054. · DOI
- Yang X, Huo F, Liu B, Liu J, Chen T, Li J, et al. Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of PI3K/Akt signaling pathway. J Mol Neurosci. 2017;61:581–9. · DOI
- Thakare R. Chapter 5 - Repurposing nonantibiotic drugs as antibacterials. 2020;34. · DOI
- Jawerbaum A, White V. Animal models in diabetes and pregnancy. Endocr Rev. 2010;31:680–701. · DOI · Paper page
- Sakurai M, Iwasa R, Sakai Y, Morimoto M. Minocycline prevents depression-like behavior in streptozotocin-induced diabetic mice. Neuropathology. 2021;41:109–17. · DOI
- Hu P, Thinschmidt JS, Yan Y, Hazra S, Bhatwadekar A, Caballero S, et al. CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol. 2013;183:1608–20. · DOI
- Nagayach A, Patro N, Patro I. Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis. 2014;29:747–61. · DOI
- Piazza FV, Segabinazi E, Centenaro LA, do Nascimento PS, Achaval M, Marcuzzo S. Enriched environment induces beneficial effects on memory deficits and microglial activation in the hippocampus of type 1 diabetic rats. Metab Brain Dis. 2014;29:93–104. · DOI
- Renaud J, Bassareo V, Beaulieu J, Pinna A, Schlich M, Lavoie C, et al. Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway. Neurobiol Aging. 2018;69:117–28. · DOI
- Ramos-Rodriguez JJ, Infante-Garcia C, Galindo-Gonzalez L, Garcia-Molina Y, Lechuga-Sancho A, Garcia-Alloza M. Increased spontaneous central bleeding and cognition impairment in APP/PS1 mice with poorly controlled diabetes mellitus. Mol Neurobiol. 2016;53:2685–97. · DOI
- Ide M, Sonoda N, Inoue T, Kimura S, Minami Y, Makimura H, et al. The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation. PLoS ONE. 2020;15: e0228750. · DOI
- Wang Y, Wang S, Xin Y, Zhang J, Wang S, Yang Z, et al. Hydrogen sulfide alleviates the anxiety-like and depressive-like behaviors of type 1 diabetic mice via inhibiting inflammation and ferroptosis. Life Sci Nrtherlands. 2021;278: 119551. · DOI
- Bhusal A, Rahman MH, Lee I-K, Suk K. Role of hippocampal lipocalin-2 in experimental diabetic encephalopathy. Front Endocrinol. 2019;10:25. · DOI
- Elahi M, Hasan Z, Motoi Y, Matsumoto S-E, Ishiguro K, Hattori N. Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice. J Alzheimers Dis. 2016;51:1209–24. · DOI
- Han R, Liu Z, Sun N, Liu S, Li L, Shen Y, et al. BDNF alleviates neuroinflammation in the hippocampus of type 1 diabetic mice via blocking the aberrant HMGB1/RAGE/NF-kappa B pathway. Aging Dis. 2019;10:611–25. · DOI
- Oliveira WH, Nunes AK, Rocha Franca ME, Santos LA, Los DB, Rocha SW, et al. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res. 2016;1644:149–60. · DOI · Paper page
- Paladugu L, Gharaibeh A, Kolli N, Learman C, Hall TC, Li L, et al. Liraglutide has anti-inflammatory and anti-amyloid properties in streptozotocin-induced and 5xFAD mouse models of Alzheimer’s disease. IJMS. 2021;22:860. · DOI
- Hu P, Thinschmidt JS, Caballero S, Adamson S, Cole L, Chan-Ling T, et al. Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice. Am J Physiol Endocrinol Metab. 2015;308:E688–98. · DOI
- Lee JY, Park CS, Choi HY, Yune TY. Ginseng extracts, GS-KG9 and GS-E3D, prevent blood–brain barrier disruption and thereby inhibit apoptotic cell death of hippocampal neurons in streptozotocin-induced diabetic rats. Nutrients. 2020;12:2383. · DOI
- Glaser N, Little C, Lo W, Cohen M, Tancredi D, Wulff H, et al. Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain. Pediatr Diabetes Denmark. 2017;18:356–66. · DOI
- Wang K, Song F, Wang H, Wang J, Sun Y. Quetiapine attenuates the neuroinflammation and executive function deficit in streptozotocin-induced diabetic mice. Mediators Inflamm. 2019;2019:1236082. · DOI
- Won SJ, Yoo BH, Kauppinen TM, Choi BY, Kim JH, Jang BG, et al. Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic rats. J Neuroinflamm. 2012;9:182. · DOI
- Choi BY, Kim JH, Kim HJ, Yoo JH, Song HK, Sohn M, et al. Pyruvate administration reduces recurrent/moderate hypoglycemia-induced cortical neuron death in diabetic rats. PLoS ONE. 2013;8: e81523. · DOI
- Richa R, Yadawa AK, Chaturvedi CM. Hyperglycemia and high nitric oxide level induced oxidative stress in the brain and molecular alteration in the neurons and glial cells of laboratory mouse. Mus Musculus Neurochem Int. 2017;104:64–79. · DOI
- Luo Y, Kaur C, Ling EA. Neuronal and glial response in the rat hypothalamus–neurohypophysis complex with streptozotocin-induced diabetes. Brain Res. 2002;925:42–54. · DOI
- Klein JP, Hains BC, Craner MJ, Black JA, Waxman SG. Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus. Neurobiol Dis. 2004;15:221–8. · DOI
- Rana I, Badoer E, Alahmadi E, Leo CH, Woodman OL, Stebbing MJ. Microglia are selectively activated in endocrine and cardiovascular control centres in streptozotocin-induced diabetic rats. J Neuroendocrinol. 2014;26:413–25. · DOI
- Lo W, O’Donnell M, Tancredi D, Orgain M, Glaser N. Diabetic ketoacidosis in juvenile rats is associated with reactive gliosis and activation of microglia in the hippocampus. Pediatr Diabetes. 2016;17:127–39. · DOI
- Kawamura N, Katsuura G, Yamada-Goto N, Novianti E, Inui A, Asakawa A. Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice. Ibro Reports. 2020;9:233–40. · DOI
- Minami Y, Sonoda N, Hayashida E, Makimura H, Ide M, Ikeda N, et al. p66Shc signaling mediates diabetes-related cognitive decline. Sci Rep. 2018;8:3213. · DOI
- Wang J, Wang L, Zhou J, Qin A, Chen Z. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice. Biomed Pharmacother. 2018;106:1250–7. · DOI
- Glaser N, Chu S, Hung B, Fernandez L, Wulff H, Tancredi D, et al. Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model. BMJ Open Diabetes Res Care. 2020;8: e001793. · DOI
- Rom S, Zuluaga-Ramirez V, Gajghate S, Seliga A, Winfield M, Heldt NA, et al. Hyperglycemia-driven neuroinflammation compromises bbb leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56:1883–96. · DOI · Paper page
- Nie R, Lu J, Xu R, Yang J, Shen X, Ouyang X, et al. Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice. Aging Cell. 2022;21: e13572. · DOI
- Yu Y, Xue S, Chen K, Le Y, Zhu R, Wang S, et al. The G-protein-coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy. FASEB Bioadv. 2020;2:613–23. · DOI
- Li H, Chen D, Sun W, Chen J, Luo C, Xu H, et al. K-ATP opener attenuates diabetic-induced muller gliosis and inflammation by modulating Kir6.1 in microglia. Investig Ophthalmol Vis Sci. 2021;62:3. · DOI
- Aires ID, Madeira MH, Boia R, Rodrigues-Neves AC, Martins JM, Ambrosio AF, et al. Intravitreal injection of adenosine A(2A) receptor antagonist reduces neuroinflammation, vascular leakage and cell death in the retina of diabetic mice. Sci Rep. 2019;9:17207. · DOI
- Du A, Xie Y, Ouyang H, Lu B, Jia W, Xu H, et al. Si-Miao-Yong-An decoction for diabetic retinopathy: a combined network pharmacological and in vivo approach. Front Pharmacol. 2021;12:763163–763163. · DOI
- Elsherbiny NM, Ahmad S, Naime M, Elsherbini AM, Fulzele S, Al-Gayyar MM, et al. ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. Life Sci. 2013;93:78–88. · doi:10.1016/j.lfs.2013.05.024
- Mei X-Y, Zhou L-Y, Zhang T-Y, Lu B, Ji L-L. Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int J Ophthalmol. 2017;10:870–7.
- Ouyang H, Mei X, Zhang T, Lu B, Ji L. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Eur J Pharmacol Netherlands. 2018;840:20–7. · DOI
- Dietrich N, Kolibabka M, Busch S, Bugert P, Kaiser U, Lin J, et al. The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PLoS ONE. 2016;11: e0167853. · DOI
- Ahmad S, ElSherbiny NM, Jamal MS, Alzahrani FA, Haque R, Khan R, et al. Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy. J Neuroimmunol. 2016;295:47–53. · DOI
- Campos A, Campos EJ, Martins J, Rodrigues FSC, Silva R, Ambrosio AF. Inflammatory cells proliferate in the choroid and retina without choroidal thickness change in early type 1 diabetes. Exp Eye Res. 2020;199: 108195. · DOI
- Chen X, Zhou H, Gong Y, Wei S, Zhang M. Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes. Graefes Arch Clin Exp Ophthalmol. 2015;253:519–25. · DOI
- Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, Khan S, et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes. 2011;60:1122–33. · DOI · Paper page
- Ibrahim AS, El-Shishtawy MM, Pena A, Liou GI. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis. 2010;16:2033–42.
- Jiang M, Xie H, Zhang C, Wang T, Tian H, Lu L, et al. Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy. J Cell Mol Med. 2022;26:1229–44. · DOI
- Krady JK, Basu A, Allen CM, Xu YP, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005;54:1559–65. · DOI · Paper page
- Park YG, Lee J-Y, Kim C, Park Y-H. Early microglial changes associated with diabetic retinopathy in rats with streptozotocin-induced diabetes. J Diabetes Res. 2021;2021:4920937. · DOI
- Xie H, Zhang C, Liu D, Yang Q, Tang L, Wang T, et al. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy. Diabetologia. 2021;64:211–25. · DOI
- Ting KK, Zhao Y, Shen W, Coleman P, Yam M, Chan-Ling T, et al. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models. Diabetologia. 2019;62:322–34. · DOI
- Ma K, Xu Y, Wang C, Li N, Li K, Zhang Y, et al. A cross talk between class a scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy. Am J Physiol Endocrinol Metab. 2014;307:E1153–65. · DOI
- McVicar CM, Ward M, Colhoun LM, Guduric-Fuchs J, Bierhaus A, Fleming T, et al. Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. Diabetologia. 2015;58:1129–37. · DOI
- Rangasamy S, McGuire PG, Nitta CF, Monickaraj F, Oruganti SR, Das A. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS ONE. 2014;9: e108508. · DOI · Paper page
- Van Bergen T, Hu T-T, Etienne I, Reyns GE, Moons L, Feyen JHM. Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy. Exp Eye Res England. 2017;165:136–50. · DOI
- Ali SA, Zaitone SA, Dessouki AA, Ali AA. Pregabalin affords retinal neuroprotection in diabetic rats: suppression of retinal glutamate, microglia cell expression and apoptotic cell death. Exp Eye Res. 2019;184:78–90. · DOI
- Tsai GY, Cui JZ, Syed H, Xia Z, Ozerdem U, McNeill JH, et al. Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats. Clin Experiment Ophthalmol. 2009;37:223–31. · DOI
- McVicar CM, Hamilton R, Colhoun LM, Gardiner TA, Brines M, Cerami A, et al. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes. 2011;60:2995–3005. · DOI
- Yang L, Sun H, Wu L, Guo X, Dou H, Tso MOM, et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:2319–27. · DOI · Paper page
- Wang J, Lin J, Schlotterer A, Wu L, Fleming T, Busch S, et al. CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta Diabetol. 2014;51:813–21. · DOI
- Schlotterer A, Kolibabka M, Lin J, Acunman K, Dietrich N, Sticht C, et al. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model. FASEB J. 2019;33:4141–53. · DOI
- Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000;41:1971–80.
- Monickaraj F, Oruganti SR, McGuire P, Das A. A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model. Graefes Arch Clin Exp Ophthalmol. 2021;259:93–100. · DOI
- Liu Y, Biarnés Costa M, Gerhardinger C. IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulation. PLoS ONE. 2012;7: e36949. · DOI
- Liu W, Xu G, Jiang C, Da C. Expression of macrophage colony-stimulating factor (M-CSF) and its receptor in streptozotocin-induced diabetic rats. Curr Eye Res. 2009;34:123–33. · DOI
- Zhang W, Rojas M, Lilly B, Tsai N-T, Lemtalsi T, Liou GI, et al. NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation. Invest Ophthalmol Vis Sci. 2009;50:3033–40. · DOI
- Ibrahim AS, El-shishtawy MM, Zhang W, Caldwell RB, Liou GI. A(2A) adenosine receptor (A(2A)AR) as a therapeutic target in diabetic retinopathy. Am J Pathol. 2011;178:2136–45. · doi:10.1016/j.ajpath.2011.01.018
- Yu Z, Gong C, Lu B, Yang L, Sheng Y, Ji L, et al. Dendrobium chrysotoxum lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J Diabetes Res. 2015;2015:1–10.
- Beli E, Dominguez JM, Hu P, Thinschmidt JS, Caballero S, Li Calzi S, et al. CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes. J Mol Med Jmm. 2016;94:1255–65. · DOI
- Zhao F, Gao X, Ge X, Cui J, Liu X. Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy. Bioengineered. 2021;12:9266–78. · DOI
- Sun L, Wang R, Hu G, Liu H, Lv K, Duan Y, et al. Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas. Exp Eye Res. 2021;210: 108718. · DOI
- Ouyang H, Du A, Zhou L, Zhang T, Lu B, Wang Z, et al. Chlorogenic acid improves diabetic retinopathy by alleviating blood–retinal-barrier dysfunction via inducing Nrf2 activation. Phytothera Res. 2022;36:1386. · DOI
- Hu P, Hunt NH, Arfuso F, Shaw LC, Uddin MN, Zhu M, et al. Increased indoleamine 2,3-dioxygenase and quinolinic acid expression in microglia and miller cells of diabetic human and rodent retina. Invest Ophthalmol Vis Sci. 2017;58:5043–55. · DOI
- Mills SA, Jobling A, Dixon MA, Bui B, Vessey KA, Phipps JA, et al. Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy. Proc Natl Acad Sci USA. 2021;118: e2112561118. · DOI
- Portillo J-AC, Greene JA, Okenka G, Miao Y, Sheibani N, Kern TS, et al. CD40 promotes the development of early diabetic retinopathy in mice. Diabetologia. 2014;57:2222–31. · DOI
- Portillo J-AC, Corcino YL, Miao Y, Tang J, Sheibani N, Kern TS, et al. CD40 in retinal muller cells induces P2X(7)-dependent cytokine expression in macrophages/microglia in diabetic mice and development of early experimental diabetic retinopathy. Diabetes. 2017;66:483–93. · DOI
- Crespo-Garcia S, Reichhart N, Kociok N, Skosyrski S, Joussen AM. Anti-inflammatory role of netrin-4 in diabetic retinopathy. Int J Mol Sci. 2021;22:4481. · DOI
- Sharma S. High fat diet and its effects on cognitive health: alterations of neuronal and vascular components of brain. Physiol Behav. 2021;240: 113528. · DOI
- Maldonado-Ruiz R, Montalvo-Martínez L, Fuentes-Mera L, Camacho A. Microglia activation due to obesity programs metabolic failure leading to type two diabetes. Nutr Diabetes. 2017;7: e254. · DOI
- Thaler JP, Yi C-X, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122:153–62. · DOI · Paper page
- Waise TMZ, Toshinai K, Naznin F, NamKoong C, Moin ASM, Sakoda H, et al. One-day high-fat diet induces inflammation in the nodose ganglion and hypothalamus of mice. Biochem Biophys Res Commun. 2015;464:1157–62. · DOI
- Baufeld C, Osterloh A, Prokop S, Miller KR, Heppner FL. High-fat diet-induced brain region-specific phenotypic spectrum of CNS resident microglia. Acta Neuropathol. 2016;132:361–75. · DOI · Paper page
- Lee CH, Kim HJ, Lee Y-S, Kang GM, Lim HS, Lee S-H, et al. Hypothalamic macrophage inducible nitric oxide synthase mediates obesity-associated hypothalamic inflammation. Cell Rep. 2018;25:934-946.e5. · DOI
- Corraliza-Gómez M, Gallardo AB, Díaz-Marrero AR, de la Rosa JM, D’Croz L, Darias J, et al. Modulation of glial responses by furanocembranolides: leptolide diminishes microglial inflammation in vitro and ameliorates gliosis in vivo in a mouse model of obesity and insulin resistance. Mar Drugs. 2020;18:378. · DOI
- Hao S, Dey A, Yu X, Stranahan AM. Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity. Brain Behav Immun. 2016;51:230–9. · DOI · Paper page
- Vinuesa A, Pomilio C, Menafra M, Marta Bonaventura M, Garay L, Florencia Mercogliano M, et al. Juvenile exposure to a high fat diet promotes behavioral and limbic alterations in the absence of obesity. Psychoneuroendocrinology. 2016;72:22–33. · DOI
- Wang Q, Yuan J, Yu Z, Lin L, Jiang Y, Cao Z, et al. FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice. Mol Neurobiol. 2018;55:4702–17. · DOI
- Busquets O, Ettcheto M, Eritja A, Espinosa-Jimenez T, Verdaguer E, Olloquequi J, et al. c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments. J Mol Med JMM. 2019;97:1723–33. · DOI
- Wu L, Han Y, Zheng Z, Zhu S, Chen J, Yao Y, et al. Obeticholic acid inhibits anxiety via alleviating gut microbiota-mediated microglia accumulation in the brain of high-fat high-sugar diet mice. Nutrients. 2021;13:940. · DOI
- Sanchez-Sarasua S, Moustafa S, Garcia-Aviles A, Fernanda Lopez-Climent M, Gomez-Cadenas A, Olucha-Bordonau FE, et al. The effect of abscisic acid chronic treatment on neuroinflammatory markers and memory in a rat model of high-fat diet induced neuroinflammation. Nutr Metab. 2016;13:73. · DOI
- Natrus LV, Osadchuk YS, Lisakovska OO, Labudzinskyi DO, Klys YG, Chaikovsky YB. Effect of propionic acid on diabetes-induced impairment of unfolded protein response signaling and astrocyte/microglia crosstalk in rat ventromedial nucleus of the hypothalamus. Neural Plast. 2022;2022:6404964–6404964. · DOI
- Yi C-X, Tschöp MH, Woods SC, Hofmann SM. High-fat-diet exposure induces IgG accumulation in hypothalamic microglia. Dis Model Mech. 2012;5:686–90.
- Yi C-X, Walter M, Gao Y, Pitra S, Legutko B, Kälin S, et al. TNFα drives mitochondrial stress in POMC neurons in obesity. Nat Commun. 2017;8:15143. · DOI
- Gao Y, Ottaway N, Schriever SC, Legutko B, García-Cáceres C, de la Fuente E, et al. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia. 2014;62:17–25. · DOI · Paper page
- Klein C, Jonas W, Wiedmer P, Schreyer S, Akyüz L, Spranger J, et al. High-fat diet and physical exercise differentially modulate adult neurogenesis in the mouse hypothalamus. Neurosci United States. 2019;400:146–56. · DOI
- Pretz D, Le Foll C, Rizwan MZ, Lutz TA, Tups A. Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity. FASEB Journal. 2021;35. · DOI
- Romero-Juarez PA, Bulcao Visco D, Manhaes-de-Castro R, Urquiza-Martinez M, Miguel Saavedra L, Gonzalez-Vargas MC, et al. Dietary flavonoid kaempferol reduces obesity-associated hypothalamic microglia activation and promotes body weight loss in mice with obesity. Nutri Neurosci. 2021;26:26–39.
- Harrison L, Pfuhlmann K, Schriever SC, Pfluger PT. Profound weight loss induces reactive astrogliosis in the arcuate nucleus of obese mice. Mol Metab. 2019;24:149–55. · DOI
- Stein LM, Lhamo R, Cao A, Workinger J, Tinsley I, Doyle RP, et al. Dorsal vagal complex and hypothalamic glia differentially respond to leptin and energy balance dysregulation. Transl Psychiatry. 2020;10:90. · DOI
- Sugiyama M, Banno R, Yaginuma H, Taki K, Mizoguchi A, Tsunekawa T, et al. Hypothalamic glial cells isolated by MACS reveal that microglia and astrocytes induce hypothalamic inflammation via different processes under high-fat diet conditions. Neurochem Int England. 2020;136: 104733. · DOI
- Oh-I S, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, Schwartz MW. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. Am J Physiol Endocrinol Metab. 2010;299:E47-53. · DOI
- Vander Velden JW, Osborne DM. Obesity prevents S-adenosylmethionine-mediated improvements in age-related peripheral and hippocampal outcomes. Nutrients. 2021;13:1201. · DOI
- van der Harg JM, Eggels L, Ruigrok SR, Hoozemans JJM, la Fleur SE, Scheper W. Neuroinflammation is not a prerequisite for diabetes-induced tau phosphorylation. Front Neurosci. 2015;9:432. · DOI
- Lee J-J, Wang P-W, Yang I-H, Huang H-M, Chang C-S, Wu C-L, et al. High-fat diet induces toll-like receptor 4-dependent macrophage/microglial cell activation and retinal impairment. Invest Ophthalmol Vis Sci. 2015;56:3041–50. · DOI
- Li X, Cai Y, Luo J, Ding J, Yao G, Xiao X, et al. Metformin attenuates hypothalamic inflammation via downregulation of RIPK1-independent microglial necroptosis in diet-induced obese mice. Cell Death Discov. 2021;7:338. · DOI
- Sheikh MH, Errede M, D’Amati A, Khan NQ, Fanti S, Loiola RA, et al. Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: therapeutic avenues. FASEB J. 2022;36: e22107. · DOI
- Tsunekawa T, Banno R, Mizoguchi A, Sugiyama M, Tominaga T, Onoue T, et al. Deficiency of PTP1B attenuates hypothalamic inflammation via activation of the JAK2-STAT3 pathway in microglia. EBioMedicine. 2017;16:172–83. · DOI
- Fioravante M, Bombassaro B, Ramalho AF, de Moura RF, Haddad-Tovolli R, Solon C, et al. Hypothalamic expression of the atypical chemokine receptor ACKR2 is involved in the systemic regulation of glucose tolerance. BBA Mol Basis Dis. 2019;1865:1126–37. · DOI
- Morari J, Anhe GF, Nascimento LF, de Moura RF, Razolli D, Solon C, et al. Fractalkine (CX3CL1) is involved in the early activation of hypothalamic inflammation in experimental obesity. Diabetes. 2014;63:3770–84. · DOI
- Kawamura N, Katsuura G, Yamada-Goto N, Novianti E, Inui A, Asakawa A. Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice. BMJ Open Diabetes Res Care. 2021;9. · DOI
- Dorfman MD, Krull JE, Douglass JD, Fasnacht R, Lara-Lince F, Meek TH, et al. Sex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice. Nat Commun. 2017;8:14556. · DOI · Paper page
- Robison LS, Albert NM, Camargo LA, Anderson BM, Salinero AE, Riccio DA, et al. High-fat diet-induced obesity causes sex-specific deficits in adult hippocampal neurogenesis in mice. Eneuro. 2019;2020(7):0391–419.
- Syeda T, Sánchez-Tapia M, Orta I, Granados-Portillo O, Pérez-Jimenez L, Rodríguez-Callejas J-D, et al. Bioactive foods decrease liver and brain alterations induced by a high-fat-sucrose diet through restoration of gut microbiota and antioxidant enzymes. Nutrients. 2021;14. · DOI
- Minaya DM, Turlej A, Joshi A, Nagy T, Weinstein N, DiLorenzo P, et al. Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats. Nutr Diabetes. 2020;10:20. · DOI
- Wang J, Li Y, Lai K, Zhong Q, Demin KA, Kalueff A, et al. High-glucose/high-cholesterol diet in zebrafish evokes diabetic and affective pathogenesis: the role of peripheral and central inflammation, microglia and apoptosis. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96: 109752. · DOI
- Wu M, Liao M, Huang R, Chen C, Tian T, Wang H, et al. Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia. Genes Dis. 2022;9:401–14. · DOI
- Tarantini S, Valcarcel-Ares MN, Yabluchanskiy A, Tucsek Z, Hertelendy P, Kiss T, et al. Nrf2 deficiency exacerbates obesity-induced oxidative stress, neurovascular dysfunction, blood-brain barrier disruption, neuroinflammation, amyloidogenic gene expression, and cognitive decline in mice, mimicking the aging phenotype. J Gerontol A Biol Sci Med Sci. 2018;73:853–63. · DOI · Paper page
- Yi C-X, Al-Massadi O, Donelan E, Lehti M, Weber J, Ress C, et al. Exercise protects against high-fat diet-induced hypothalamic inflammation. Physiol Behav. 2012;106:485–90. · DOI
- Pfuhlmann K, Schriever SC, Legutko B, Baumann P, Harrison L, Kabra DG, et al. Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice. J Neuroinflamm. 2018;15:35. · DOI · Paper page
- Little K, Llorián-Salvador M, Scullion S, Hernández C, Simó-Servat O, del Marco A, et al. Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline. Trends Endocrinol Metab. 2021. · DOI
- Hammoum I, Mbarek S, Dellaa A, Dubus E, Baccouche B, Azaiz R, et al. Study of retinal alterations in a high fat diet-induced type ii diabetes rodent: meriones shawi. Acta Histochem. 2017;119:1–9. · DOI
- Atawia RT, Bunch KL, Fouda AY, Lemtalsi T, Eldahshan W, Xu Z, et al. Role of arginase 2 in murine retinopathy associated with western diet-induced obesity. J Clin Med. 2020;9:317. · DOI
- Jo DH, Yun J-H, Cho CS, Kim JH, Kim JH, Cho C-H. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. Glia. 2019;67:321–31. · DOI
- Brykczynska U, Geigges M, Wiedemann SJ, Dror E, Boeni-Schnetzler M, Hess C, et al. Distinct transcriptional responses across tissue-resident macrophages to short-term and long-term metabolic challenge. Cell Rep. 2020;30:1627. · DOI
- Gholamhosseinian A, Abbasalipourkabir R, Ziamajidi N, Sayadi M, Sayadi K. The anti-inflammatory effect of omega-3 polyunsaturated fatty acids dramatically decreases by iron in the hippocampus of diabetic rats. Life Sci. 2020;245: 117393. · DOI
- Lang X, Zhao N, He Q, Li X, Li X, Sun C, et al. Treadmill exercise mitigates neuroinflammation and increases BDNF via activation of SIRT1 signaling in a mouse model of T2DM. Brain Res Bull. 2020;165:30–9. · DOI
- Zhang P-A, Sun Q, Li Y-C, Weng R-X, Wu R, Zhang H-H, et al. Overexpression of purinergic P2X4 receptors in hippocampus rescues memory impairment in rats with type 2 diabetes. Neurosci Bull. 2020;36:719–32. · DOI
- Li X, He J, Li X, Li Y, Zhou Y, Cai S. Neu-P11-a novel melatonin receptor agonist, could improve the features of type-2 diabetes mellitus in rats. Endokrynol Pol. 2021;72:634–42. · DOI
- Kleinert M, Clemmensen C, Hofmann SM, Moore MC, Renner S, Woods SC, et al. Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol. 2018;14:140–62. · DOI · Paper page
- Lindström P. The physiology of obese-hyperglycemic mice [ob/ob Mice]. Sci World J. 2007;7:666–85. · DOI · Paper page
- Shinohara M, Tashiro Y, Shinohara M, Hirokawa J, Suzuki K, Onishi-Takeya M, et al. Increased levels of A beta 42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes. FASEB J. 2020;34:2425–35. · DOI
- Shinohara M, Kikuchi M, Onishi-Takeya M, Tashiro Y, Suzuki K, Noda Y, et al. Upregulated expression of a subset of genes in APP;ob/ob mice: evidence of an interaction between diabetes-linked obesity and Alzheimer’s disease. FASEB Bioadv. 2021;3:323–33. · DOI
- Lee VK, Hosking BM, Holeniewska J, Kubala EC, von Leithner PL, Gardner PJ, et al. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Diabetologia. 2018;61:2422–32. · DOI
- Zhang J, Zhang Y, Yuan Y, Liu L, Zhao Y, Wang X. Gut microbiota alteration is associated with cognitive deficits in genetically diabetic (Db/db) mice during aging. Front Aging Neurosci. 2022;13: 815562. · DOI
- Ramos-Rodriguez JJ, Jimenez-Palomares M, Murillo-Carretero MI, Infante-Garcia C, Berrocoso E, Hernandez-Pacho F, et al. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer’s disease. Psychoneuroendocrinology. 2015;62:69–79. · DOI
- Infante-Garcia C, Jose Ramos-Rodriguez J, Galindo-Gonzalez L, Garcia-Alloza M. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes. Psychoneuroendocrinology. 2016;65:15–25. · DOI
- Infante-Garcia C, Jose Ramos-Rodriguez J, Marin-Zambrana Y, Teresa Fernandez-Ponce M, Casas L, Mantell C, et al. Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model. Brain Pathol. 2017;27:499–507. · DOI
- Hierro-Bujalance C, Infante-Garcia C, del Marco A, Herrera M, Carranza-Naval MJ, Suarez J, et al. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes. Alz Res Therapy. 2020;12:40. · DOI · Paper page
- Carranza-Naval MJ, del Marco A, Hierro-Bujalance C, Alves-Martinez P, Infante-Garcia C, Vargas-Soria M, et al. Liraglutide reduces vascular damage, neuronal loss, and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes. Front Aging Neurosci. 2021;13: 741923. · DOI
- Liu Y, Chen D, Smith A, Ye Q, Gao Y, Zhang W. Three-dimensional remodeling of functional cerebrovascular architecture and gliovascular unit in leptin receptor-deficient mice. J Cereb Blood Flow Metab. 2021;41:1547–62. · DOI
- Dey A, Hao S, Erion JR, Wosiski-Kuhn M, Stranahan AM. Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes. J Neuroimmunol. 2014;269:20–7. · DOI
- Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK, et al. Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J Neurosci. 2014;34:2618–31. · DOI · Paper page
200 of 257 shown
Cited by
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
Zhu, J., Hu, Z., Luo, Y., Liu, Y., Luo, W., Du, X., Luo, Z., Hu, J., & Peng, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265372 · Cited by 310
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Distribution of lipid droplets in hippocampal neurons and microglia: impact of diabetes and exercise
Seferi, G., Mjønes, H. S., Havik, M., Reiersen, H., Dalen, K. T., Nordengen, K., & Morland, C. (2024) · Life Science Alliance · doi:10.26508/lsa.202302239 · Cited by 9
Pallais, J. P., Razzoli, M., Rodriguez, P., McGonigle, S., Daugherty, A., Hillman, H., Verteramo, L., Schrank, P. R., Parthiban, P., Chang, X., et al. (2026) · doi:10.64898/2026.04.18.719397 · Cited by 1
Metadata
- Authors
- Vargas-Soria, M., García-Alloza, M., & Corraliza-Gómez, M.
- Venue
- Journal of Neuroinflammation
- Published
- 2023-03-03
- Volume
- 20
- Issue
- 1
- ISSN
- 1742-2094
- PMC
- PMC9983227
- Cited by
- 104
- References
- 23
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Agencia Estatal de Investigacion. Ministerio de Ciencia e Innovación (PID2020-115499RB-I00)
- Junta de Andalucía (P20-00928)
- Universidad de Cadiz
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies. https://app.cochat.ai/papers/10.1186/s12974-023-02740-x
- The paper
- Vargas-Soria, M., García-Alloza, M., & Corraliza-Gómez, M. (2023). Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-023-02740-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.